These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3147914)

  • 1. [Effect of the (Fab')2 fragment of the anti-Pseudomonas aeruginosa antibodies on Pseudomonas-induced keratitis in rats].
    Ren PX
    Yan Ke Xue Bao; 1986 Dec; 2(4):255-7. PubMed ID: 3147914
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.
    Welsh NH; Rauch AJ; Gaffin SL
    Br J Ophthalmol; 1984 Nov; 68(11):828-32. PubMed ID: 6437435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M; Brückner O; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study on the immunotherapy for the Pseudomonas keratitis in rabbits (author's transl)].
    Tanaka N; Ohzeki T; Tanaka I; Kinoshita N
    Nippon Ganka Gakkai Zasshi; 1977 Sep; 81(9):1252-9. PubMed ID: 415535
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
    Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
    Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
    Shime N; Sawa T; Fujimoto J; Faure K; Allmond LR; Karaca T; Swanson BL; Spack EG; Wiener-Kronish JP
    J Immunol; 2001 Nov; 167(10):5880-6. PubMed ID: 11698464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications].
    Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa
    Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model.
    Uwaydat S; Jha P; Tytarenko R; Brown H; Wiggins M; Bora PS; Bora NS
    Curr Eye Res; 2011 Sep; 36(9):787-96. PubMed ID: 21812661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
    Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
    Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
    Minukhin VV; Tsyganenko AIa
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
    Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S
    Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K; Wiener-Kronish JP; Sawa T
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K; Melnitzki S; Pilz G; Reuschel-Janetschek E
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa. Vaccines and immunotherapy.
    Pennington JE
    Infect Dis Clin North Am; 1990 Jun; 4(2):259-70. PubMed ID: 2111838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advisability of using donor blood immunoglobulin preparations for treating infections caused by Pseudomonas aeruginosa].
    Nazarchuk LV
    Klin Khir (1962); 1991; (1):23-4. PubMed ID: 1712409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective effect of anti-Pseudomonas blood preparations].
    Nazarchuk LV; Koval' AI
    Fiziol Zh (1994); 2001; 47(6):55-7. PubMed ID: 11962093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental chronic Pseudomonas aeruginosa lung infection in rats. Non-specific stimulation with LPS reduces lethality as efficiently as specific immunization.
    Lange KH; Hougen HP; Høiby N; Fomsgaard A; Rygaard J; Johansen HK
    APMIS; 1995 May; 103(5):367-74. PubMed ID: 7654361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.